Verisk Adds Insurance Data to Amazon Quick, Copilot and Claude
Oct 29, 2026
Enterprise
QuVa Pharma Secures National Drug Diversion Software Agreement with Premier
May 5, 2026
QuVa Pharma has been awarded a national group purchasing agreement with Premier, Inc. for its Drug Diversion Software Solutions, effective May 1, 2026. The deal enables Premier members to access pre-negotiated pricing and terms for QuVa's BrightStream platform, which supports controlled substance oversight and compliance.
QuVa Pharma has been awarded a national group purchasing agreement with Premier, Inc. for its Drug Diversion Software Solutions, announced in a press release. The agreement took effect on May 1, 2026, and allows Premier members to access special pricing and terms negotiated by Premier.
The partnership expands QuVa's relationship with Premier through its BrightStream platform, which uses analytics to help health systems monitor and manage diversion risk. The software provides visibility into controlled substance activity, supports investigations, and generates documentation for regulatory compliance.
According to QuVa, BrightStream also offers reporting, benchmarking, and workflow management tools that unify pharmacy, nursing, and compliance operations. The platform aims to replace manual processes with standardized oversight across hospital systems.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 13 ETR survey: Claude leads enterprise AI tools on satisfaction and spending plans Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 Gondola says Codex lifted engineering output 25% as revenue more than doubled Nov 13 DuPont teams with Microsoft and NobleAI to speed up R&D with AI Nov 13 Korean AI startups fear Huang exit could delay planned NVIDIA investmentsMore from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
INmune Bio and QCi Apply Quantum Computing to XPro Research
Oct 14, 2026
Life Sciences
Trinity Acquires Verix to Add Tovana to TrinityEDGE
Oct 20, 2026
Acquisitions
Midstream Health Raises $20M to Recover Hospital Payments
Nov 01, 2026
Funding
Vanta to acquire Israeli AI security startup Pillar Security for about $150 million
Nov 09, 2026
Acquisitions
Navara Technologies Acquires PieQ and Its FLOW AI Platform
Oct 14, 2026
Acquisitions
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.